• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER BIOMET, INC. PERONA FEMUR CEMENTED CRUCIATE RETAINING (CR) STANDARD NITRIDED; PROSTHESIS, KNEE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER BIOMET, INC. PERONA FEMUR CEMENTED CRUCIATE RETAINING (CR) STANDARD NITRIDED; PROSTHESIS, KNEE Back to Search Results
Catalog Number 42572606402
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Loss of Range of Motion (2032); Arthrofibrosis (4885)
Date of Event 04/02/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the patient underwent an initial right total knee arthroplasty completed.Approximately 3 months post-op, the patient experienced stiffness and limited range of motion.Subsequently, the patient underwent a manipulation under anesthesia and the patient's symptoms have reportedly improved.Attempts have been made and all available information has been provided.
 
Additional Manufacturer Narrative
(b)(4).D10: 42522000410 - psn asf cr 10mm ve r 3-9 cd - 66686648, 42532006702 - tibia cemented 5 degree stemmed right size d - 66844647, unknown - unknown simplex cement - unknown.No product was returned, or pictures provided; visual and dimensional evaluations could not be performed.Arthrofibrosis is defined as the development of fibrous scar tissue within or surrounding a joint.Arthrofibrosis is a known postoperative procedure related complication that can occur from surgical implantation of new joint replacement as well as from previous injuries or surgical procedures.Scar tissue formation is a normal healing response; however, the buildup of such can result in pain, stiffness, limited range of motion, and difficulty properly ambulating.If excess scar tissue develops, conservative measures such as exercises or physical therapy would be attempted first.If these attempts fail, surgical intervention such as manipulation under anesthesia, arthroscopic arthrolysis, or open arthrotomy would become necessary to remove the fibrous tissue and restore joint function.Root cause of the reported event is not device related.If any further information is found which would change or alter any conclusions or information, a supplemental report will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERONA FEMUR CEMENTED CRUCIATE RETAINING (CR) STANDARD NITRIDED
Common Device Name
PROSTHESIS, KNEE
Manufacturer (Section D)
ZIMMER BIOMET, INC.
1800 w. center st.
warsaw IN 46580
Manufacturer (Section G)
ZIMMER BIOMET, INC.
1800 w. center st.
warsaw IN 46580
Manufacturer Contact
jennifer rapsavage
56 e. bell dr.
warsaw, IN 46582
5745260384
MDR Report Key22936296
Report Number0001822565-2025-03205
Device Sequence Number9920030
Product Code JWH
UDI-Device Identifier00889024576186
UDI-Public(01)00889024576186(17)341010(10)66808755
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
K193223
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Study,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 09/02/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Catalogue Number42572606402
Device Lot Number66808755
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/11/2025
Initial Report FDA Received Date09/02/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured10/16/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H11.
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient SexFemale
Patient Weight78 KG
Patient RaceBlack Or African American
-
-